Diamond Hill Capital Management
ABBV icon

Diamond Hill Capital Management’s AbbVie ABBV Stock Holding History

Diamond Hill Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,010,175
Closed -$180M – 175
2024
Q4 		$180M Sell
1,010,175
-307,509
-23% -$56.5M 0.79% 49
2024
Q3 		$260M Sell
1,317,684
-39,080
-3% -$7.29M 1.05% 42
2024
Q2 		$233M Buy
1,356,764
+13,787
+1% +$2.28M 1% 47
2024
Q1 		$245M Sell
1,342,977
-1,891
-0.1% -$326K 1% 48
2023
Q4 		$208M Buy
1,344,868
+29,550
+2% +$4.31M 0.92% 49
2023
Q3 		$196M Sell
1,315,318
-14,249
-1% -$2.09M 0.95% 46
2023
Q2 		$179M Buy
1,329,567
+3,874
+0.3% +$568K 0.81% 51
2023
Q1 		$211M Sell
1,325,693
-24,979
-2% -$3.82M 0.99% 44
2022
Q4 		$218M Sell
1,350,672
-197,335
-13% -$30.3M 0.99% 46
2022
Q3 		$208M Sell
1,548,007
-66,975
-4% -$9.61M 1% 43
2022
Q2 		$247M Sell
1,614,982
-265,808
-14% -$40.6M 1.08% 39
2022
Q1 		$305M Sell
1,880,790
-331,112
-15% -$48.1M 1.13% 37
2021
Q4 		$299M Sell
2,211,902
-147,089
-6% -$17.4M 1.07% 37
2021
Q3 		$254M Buy
2,358,991
+46,301
+2% +$5.29M 0.97% 42
2021
Q2 		$261M Buy
2,312,690
+44,704
+2% +$5.03M 0.99% 42
2021
Q1 		$245M Buy
2,267,986
+2,152,780
+1,869% +$230M 0.99% 41
2020
Q4 		$12.3M Buy
115,206
+4,114
+4% +$395K 0.06% 121
2020
Q3 		$9.73M Hold
111,092
– – 0.05% 117
2020
Q2 		$10.9M Buy
+111,092
New +$9.78M 0.06% 115

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Diamond Hill Capital Management's ABBV Position: Q1 2025 in Review

Diamond Hill Capital Management sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 1,010,175 shares — an estimated $180M sold.

Diamond Hill Capital Management first reported a position in ABBV in Q2 2020 and held it in 19 quarters. The position peaked at $305M in Q1 2022. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Diamond Hill Capital Management reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • Diamond Hill Capital Management sold 1,010,175 AbbVie shares in Q1 2025, an estimated $180M.
  • Diamond Hill Capital Management first reported a position in AbbVie in Q2 2020 and held it in 19 quarters.
  • Diamond Hill Capital Management's AbbVie position peaked at $305M in Q1 2022.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Diamond Hill Capital Management's 13F filing for Q1 2025, filed 6 May 2025.